AMD

RAHWAY, N.J., April 2, 2026 Merck (MSD) has announced the initiation of a pivotal Phase 2b/3 clinical trial (MALBEC)...

BLOOMINGTON, Minn., USA, March 31, 2026 i-Lumen Scientific has received FDA Investigational Device Exemption (IDE) approval to initiate U.S....